Headline News about Gilead Sciences
What Analysts Are Saying About Gilead Sciences Stock
December 10, 2024
Via Benzinga
Looking At Gilead Sciences's Recent Unusual Options Activity
December 03, 2024
Via Benzinga
Price Over Earnings Overview: Gilead Sciences
November 25, 2024
Via Benzinga
26 Analysts Assess Gilead Sciences: What You Need To Know
November 18, 2024
Via Benzinga
Here's How Much $1000 Invested In Gilead Sciences 20 Years Ago Would Be Worth Today
November 06, 2024
Via Benzinga
Gilead Sciences's Earnings: A Preview
November 05, 2024
Via Benzinga
Peering Into Gilead Sciences's Recent Short Interest
October 21, 2024
Via Benzinga
Trump's Victory Spurs $50B Corporate Bond Surge As Tax Cut Optimism Drives Borrowing Costs To 25-Year Low
November 15, 2024
Via Benzinga
Topics
Government
Exposures
Political
Evaluating Gilead Sciences: Insights From 15 Financial Analysts
October 21, 2024
Via Benzinga
HIV Drugmaker Gilead Reports Strongest Quarterly Performance Of 2024, Analysts Boost Price Target On Raised Outlook
November 07, 2024
Via Benzinga
Topics
Earnings
Exposures
Financial
Nasdaq 100 Extends Record Levels Ahead Of Fed Meeting, Tesla Hits 26-Month Highs, Small Caps Stall: What's Driving Markets Thursday?
November 07, 2024
Via Benzinga
Topics
Economy
Exposures
Interest Rates
Gilead Sciences (GILD) Q3 2024 Earnings Call Transcript
November 06, 2024
Via The Motley Fool
Topics
Earnings
Exposures
Financial
Via Benzinga
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.